# Beckman Coulter, Inc., Chaska, MN – FDA Inspections

Source: https://www.keypedia.com/companies/beckman-coulter-inc/3dff0b83-5add-471e-8c42-4d45ae01cf2b

> Inspection records and compliance data for Beckman Coulter, Inc. in Chaska, Minnesota. 7 FDA inspections on record (1 OAI), 2 Form 483s, last inspected January 17, 2025.

---

## Details

- Name: Beckman Coulter, Inc.
- FEI Number: 2122870
- Address Line 1: 1000 Lake Hazeltine Dr
- City: Chaska
- State: Minnesota
- Zip Code: 55318
- Country Name: United States
- Address: 1000 Lake Hazeltine Dr, Chaska, Minnesota 55318, United States
- Country: United States

## Related Documents

- FDA Inspection 1247509 - Beckman Coulter, Inc. - 2025-01-17 — source: FDA, date: January 17, 2025
- FDA Inspection 1247509 - Beckman Coulter, Inc. - 2025-01-17 — classification: No Action Indicated (NAI), source: FDA, date: January 17, 2025
- [483 - Beckman Coulter, Inc. - 2024-12-13](https://www.keypedia.com/records/483/beckman-coulter-inc/ce5f4dd4-9fe4-4ee0-8eb5-bf1928792790) — source: FDA, date: December 13, 2024
- FDA Inspection 1248406 - Beckman Coulter, Inc. - 2024-12-13 — source: FDA, date: December 13, 2024
- [FDA Inspection 1248406 - Beckman Coulter, Inc. - 2024-12-13](https://www.keypedia.com/records/fda_inspections/beckman-coulter-inc/99bc012c-cccd-4f89-8c51-2a6cadde1cb8) — source: FDA, date: December 13, 2024
- [483 - Beckman Coulter, Inc. - 2023-12-11](https://www.keypedia.com/records/483/beckman-coulter-inc/19faf556-d51c-4212-a756-6587a52fa301) — source: FDA, date: December 11, 2023
- [FDA Inspection 1224836 - Beckman Coulter, Inc. - 2023-12-11](https://www.keypedia.com/records/fda_inspections/beckman-coulter-inc/633ab933-b437-41ab-bddc-974a61dab3c8) — classification: Official Action Indicated (OAI), source: FDA, date: December 11, 2023
- FDA Inspection 1224836 - Beckman Coulter, Inc. - 2023-12-11 — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 11, 2023
- FDA Inspection 1051201 - Beckman Coulter, Inc. - 2017-11-03 — source: FDA, date: November 3, 2017
- FDA Inspection 837631 - Beckman Coulter, Inc. - 2013-06-19 — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2013
- [FDA Inspection 837631 - Beckman Coulter, Inc. - 2013-06-19](https://www.keypedia.com/records/fda_inspections/beckman-coulter-inc/d9422bb0-48de-4b00-ac97-004d7a690d58) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 19, 2013
- FDA Inspection 783029 - Beckman Coulter, Inc. - 2012-05-17 — classification: No Action Indicated (NAI), source: FDA, date: May 17, 2012

## Related Companies

- [Draeger Medical Systems, Inc.](https://www.keypedia.com/companies/draeger-medical-systems-inc/361285bb-e4c9-4778-bd58-59caf9885b61)
- [FHC, Inc.](https://www.keypedia.com/companies/fhc-inc/ad3d6d9e-f0ec-4265-83c6-9d06e50ca1da)
- [Coapt LLC](https://www.keypedia.com/companies/coapt-llc/32959b76-e0c9-422d-92e7-d12579b7020c)
- [Davryan Laboratories, Inc.](https://www.keypedia.com/companies/davryan-laboratories-inc/0dfc120f-19f4-418f-b184-f2fd358c6847)
- [Poiesis Medical, LLC](https://www.keypedia.com/companies/poiesis-medical-llc/03a8a2d5-3e29-45b1-9b42-c9df9d88ca8e)
- [Northwest Eye Design, LLC](https://www.keypedia.com/companies/northwest-eye-design-llc/eb08662b-92e1-4cb6-9dbf-f780fbf30a22)
- [Neurolumen LLC](https://www.keypedia.com/companies/neurolumen-llc/2e53eb6e-6247-4069-ade9-cef49b1b8f04)
- [CNMC Company, Inc.](https://www.keypedia.com/companies/cnmc-company-inc/e9b17972-db25-41f6-b8a0-ea077d6ee24d)
- [R&D Engineering, Inc. of Earlham](https://www.keypedia.com/companies/rd-engineering-inc-of-earlham/2f399ceb-79e5-476a-9bed-93247ecfebcd)
- [NeuroLogica Corporation](https://www.keypedia.com/companies/neurologica-corporation/112b8be4-8d99-4b9b-b6f8-0335d0ba9af0)

## Related Officers

- [Investigator ](https://www.keypedia.com/people/christina-l-bigham/f3da8e26-4a8c-43a8-8070-349fe4500289)
- [Albert L. Nguyen](https://www.keypedia.com/people/albert-l-nguyen/496338d0-71c4-43da-92f0-09515559d9fc)